Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 1/20 | 0.37 |
| ▸ | BCR | P11274 | 1/20 | 0.37 |
| ▸ | AKT1 | P31749 | 2/20 | 0.36 |
| ▸ | AKT2 | P31751 | 1/20 | 0.35 |
| ▸ | AKT3 | Q9Y243 | 1/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | HTR7 | P34969 | 1/20 | 0.34 |
| ▸ | METAP2 | P50579 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21392302 | 0.81 | ABL1 (0.43) | ABL1BCRAKT1TRPV1ALDH1A1 | |
| SCHEMBL14932219 | 0.78 | P2RX4 (0.38) | TRPV1ALDH1A1MAPTNPSR1LMNA | |
| SCHEMBL21381185 | 0.78 | P2RX4 (0.33) | ALDH1A1NPSR1NR1H2NR1H3 | |
| SCHEMBL19794965 | 0.77 | HTR7 (0.40) | ALDH1A1MAPTRAB9APOLBHPGD | |
| SCHEMBL17948187 | 0.74 | CCR1 (0.42) | ABL1BCRTRPV1ALDH1A1MAPT | |
| SCHEMBL17948183 | 0.74 | CCR1 (0.42) | ABL1BCRTRPV1ALDH1A1MAPT | |
| SCHEMBL13308158 | 0.73 | EGLN1 (0.40) | MAPTNPSR1RAB9APOLBKMT2A | |
| SCHEMBL17948180 | 0.73 | SMN1; SMN2 (0.40) | ABL1BCRTRPV1ALDH1A1MAPT | |
| SCHEMBL17489943 | 0.73 | PDK2 (0.38) | HTR7 | |
| SCHEMBL21392426 | 0.72 | JAK2 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10886477-B2 | Iridium complex and organic electroluminescence device using the same | UDC IRELAND LIMITED (IE) | 2021-01-05 | — | — | US | disclosed |
| US-20190296251-A1 | IRIDIUM COMPLEX AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORPORATION (TW) | 2019-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190296251-A1 | IRIDIUM COMPLEX AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IMPA1, LAGE3, OCIAD1 | ABL1 1855/4885BCR 3443/4885AKT1 2935/4885 |
| US-10886477-B2 | Iridium complex and organic electroluminescence device using the same | IMPA1, LAGE3, OCIAD1 | ABL1 1855/4885BCR 3443/4885AKT1 2935/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.